Company Overview
Company Type: Private Company
Website: www.synaptivemedical.com
Number of Employees: -
Year Founded: 2012
Total Amount Raised (CAD mm)†: 283.89
Total Rounds of Funding**:14
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Synaptive Medical Inc. develops and supports integrated systems and solutions that combine informatics, imaging, surgical planning, navigation and advanced optics, to solve challenges both in and beyond the operating room through collaboration with surgeons and hospitals. The company develops BrightMatter Prime that enables pre-operative preparation and planning with life-like visualization tools, images, and workflow in the surgical suite; BrightMatter Servo that unites high-definition imaging capabilities and hands-free operation while delivering 3D tractography-powered navigation into the surgical suite in a single solution; and ImageDrive, which is a web-enabled solution that integrates a patient’s digital footprint across their circle of care and addresses the data management needs of both clinical workflows and clinical research. It also offers BrightMatter Simulate, which offers a realistic experience for practicing neurosurgeries in a single and integrated training solution; BrightMatter Plan that automatically generates whole-brain tractography allowing users to review tracts and explore multiple surgical approaches to create pre-operative plans; BrightMatter Guide that allows surgeons to bring all of the neurosurgical features of BrightMatter Plan software with them into the surgical suite, by emphasizing the 3D visualization of pre-operative tractographic imaging; BrightMatter Drive that delivers the optical component where and when the surgeon needs it; BrightMatter Vision that incorporates the visualization power of a surgical microscope with flexibility and ergonomics to provide imaging and comfort when operating within the surgical suite; and Modus Plan, a surgical planning tool. The company also provides evidence-based studies and clinical research. It offers its products and solutions for neurosurgeons, radiologists, and healthcare facilities. The company was incorporated in 2012 and is based in Toronto, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
-
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
-
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Piron, Cameron 
Co-Founder, President, Chief Strategy Officer & Director
Gallop, David 
Co-Founder
Hodges, Wes 
Co-Founder
Momsen, Magnus A.
Chief Financial Officer
Campbell, Shawn 
Senior Vice President of Operations
White, Dylan 
Chief Legal Officer & Corporate Secretary
Ferro, Katrina 
Sr. Marketing & Communications Lead
Brown, Linda 
Senior Vice President of Marketing & Sales
Goldglass, Richard 
Director of HR

Key Board Members
Name
Title
Scannell, Timothy John
Chairman of the Board
Piron, Cameron 
Co-Founder, President, Chief Strategy Officer & Director
Bordessa, Daniel John
Director
Hausmann, Richard A.
Director
White, William Bradford
Director
Yang, Jing 
Director


Primary Industry Classification
Health Care Equipment


Primary Office Location
555 Richmond Street West Suite 800 | Toronto, ON | M5V 3B1 | Canada
Phone: 416-673-6679   Fax: 888-650-5230

Current and Pending Investors
Investor
Initial Investment Date
Stake Type
Current Stake Amount
Round(s)
Investment Coverage
Export Development Canada
Mar-13-2023
Minority
-
Growth
-
Sensegain Asset Management Group Co., Ltd.
Oct-29-2020
Minority
-
Venture
-
Linamar Corporation (TSX:LNR)
Dec-10-2019
Minority
-
Venture
-
Northview LifeSciences
Dec-15-2015
Unknown
-
Venture
Douglas Janzen
MaRs Discovery District, Investment Arm
-
Unknown
-
-
-

Prior Investors
General Atlantic Service Company, L.P., The Health Technology Exchange


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
ClearCanvas Inc.
ClearCanvas Inc. develops and provides medical imaging informatics software and solutions. The company is based in Toronto, Canada. As of March 9, 2015, ClearCanvas Inc. operates as a subsidiary of Synaptive Medical Inc.

United States and Canada
Health Care Technology
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Mar-13-2023
Mar-13-2023
Private Placement
Target
Synaptive Medical Inc.
Export Development Canada

50.00
Dec-31-2020
Dec-31-2020
Private Placement
Target
Synaptive Medical Inc.


80.00
Oct-29-2020
Oct-29-2020
Private Placement
Target
Synaptive Medical Inc.
Sensegain Asset Management Group Co., Ltd.

17.00
Dec-10-2019
Dec-10-2019
Private Placement
Target
Synaptive Medical Inc.
Linamar Corporation (TSX:LNR)

25.00
Mar-26-2019
Apr-05-2019
Private Placement
Target
Synaptive Medical Inc.


4.99
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Aug-10-2023
Executive/Board Changes - Other
Synaptive Medical Announces Appointment of Timothy J. Scannell as New Chair of Board of Directors
Apr-26-2023
Company Conference Presentations
Synaptive Medical Inc. Presents at 2023 Bloom Burton & Co. Healthcare Investor Conference, Apr-26-2023 01:30 PM
Mar-22-2023
Product-Related Announcements
Synaptive Announces U.S. and Canadian Availability of Next-Generation Robotic-Exoscope, Modus X
Mar-13-2023
Private Placements
Synaptive Medical Inc. announced that it has received $50 million in funding from Export Development Canada
Oct-11-2022
Strategic Alliances
Synaptive Medical Inc. Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 14, 2023 08:18 AM
Synaptive Medical Inc.
Synaptive Medical Inc
Reports
88
GlobalData

Sep 12, 2023 06:28 AM
Synaptive Medical Inc.
Synaptive Medical Inc - Medical Equipment - Deals and Alliances Profile
Reports
39
GlobalData

Jun 16, 2023 07:45 AM
Synaptive Medical Inc.
Synaptive Medical Inc
Reports
80
GlobalData

Jun 14, 2023 06:39 AM
Synaptive Medical Inc.
Synaptive Medical Inc - Medical Equipment - Deals and Alliances Profile
Reports
36
GlobalData

Mar 17, 2023 05:45 AM
Synaptive Medical Inc.
Synaptive Medical Inc - Medical Equipment - Deals and Alliances Profile
Reports
36
GlobalData

Mar 14, 2023 12:25 AM
Synaptive Medical Inc.
Synaptive Medical Inc
Reports
78
GlobalData

Dec 13, 2022 12:27 AM
Synaptive Medical Inc.
Synaptive Medical Inc
Reports
85
The Insight Partners
The Insight Partners Research Team
Nov 17, 2022 01:09 AM
Synaptive Medical Inc.
Synaptive Medical, Inc. in Global Neurosurgical Robotics Market to 2028
Notes
5
GlobalData

Oct 27, 2022 07:32 AM
Synaptive Medical Inc.
Synaptive Medical Inc - Medical Equipment - Deals and Alliances Profile
Reports
37
GlobalData

Sep 23, 2022 04:31 AM
Synaptive Medical Inc.
Synaptive Medical Inc
Reports
82


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Products
BrightMatter Guide, ImageDrive Pro

Key Board Members Details
Name
Title
Phone
Fax
Email
Scannell, Timothy John
Chairman of the Board
416-673-6679
888-650-5230

Piron, Cameron 
Co-Founder, President, Chief Strategy Officer & Director
416-673-6679
888-650-5230

Bordessa, Daniel John
Director
416-673-6679
888-650-5230
dbordessa@cyruscapital.com
Hausmann, Richard A.
Director
416-673-6679
888-650-5230

White, William Bradford
Director
416-673-6679
888-650-5230

Yang, Jing 
Director
416-673-6679
888-650-5230

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Piron, Cameron 
Co-Founder, President, Chief Strategy Officer & Director
416-673-6679
888-650-5230

Gallop, David 
Co-Founder
416-673-6679
888-650-5230

Hodges, Wes 
Co-Founder
416-673-6679
888-650-5230

Momsen, Magnus A.
Chief Financial Officer
416-673-6679
888-650-5230

Campbell, Shawn 
Senior Vice President of Operations
416-673-6679
888-650-5230

White, Dylan 
Chief Legal Officer & Corporate Secretary
-
-

Ferro, Katrina 
Sr. Marketing & Communications Lead
647-243-3355
888-650-5230
katrina.ferro@synaptivemedical.com
Brown, Linda 
Senior Vice President of Marketing & Sales
416-673-6679
888-650-5230

Goldglass, Richard 
Director of HR
416-673-6679
888-650-5230

* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
